Last reviewed · How we verify

NCT02510313

Strong Families, Thriving Children "Sugira Muryango"_Activity C

Completed NA Last updated 12 February 2020
What this trial tests

NA trial testing Sugira Muryango in Child Development, Social Protection in 2,911 participants. Completed in 1 November 2019.

Timeline
10 April 2018
Primary endpoint
1 November 2019
1 November 2019

Quick facts

Lead sponsorBoston College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment2,911
Start date10 April 2018
Primary completion1 November 2019
Estimated completion1 November 2019
Sites1 location across Rwanda

Drugs / interventions tested

Conditions studied

Sponsor

Boston College

Who can join

Adults 6 Months to 36 Months, any sex, with Child Development, Social Protection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study will test the effectiveness of the Strong Families, Thriving Children "Sugira Muryango" program as delivered by community based workers and aligned with the Rwandan social protection system. Sugira Muryango is a preventive, family-based model that uses home visiting and coaching to encourage responsive parent-child interactions and discourage violence and harsh punishment targeting families living in extreme poverty. Integration of scalable, cost-effective interventions into poverty-reduction and other social welfare programs has great potential as an effective means to promote child development and reduce familial violence and in a range of culturally diverse, low-resource settings.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effect of a home-visiting parenting program to promote early childhood development and prevent violence: a cluster-randomized trial in Rwanda.
    Jensen SK, Placencio-Castro M, Murray SM, Brennan RT, et al · · 2021 · cited 45× · PMID 33514591 · DOI 10.1136/bmjgh-2020-003508
  2. Promoting parent-child relationships and preventing violence via home-visiting: a pre-post cluster randomised trial among Rwandan families linked to social protection programmes.
    Betancourt TS, Jensen SKG, Barnhart DA, Brennan RT, et al · · 2020 · cited 40× · PMID 32375840 · DOI 10.1186/s12889-020-08693-7
  3. Measuring the cost-effectiveness of a home-visiting intervention to promote early child development among rural families linked to the Rwandan social protection system.
    Desmond C, Watt KG, Jensen SKG, Simmons E, et al · · 2023 · cited 4× · PMID 37874790 · DOI 10.1371/journal.pgph.0002473
  4. Evaluating the spillover effects of the Sugira Muryango home-visiting intervention on temperament of children aged (0.3-3years) exposed to domestic violence: A cluster randomized controlled trial.
    Siboyintore T, Ntete JM, Mutabaruka J, Betancourt T, et al · · 2025 · cited 1× · PMID 40163481 · DOI 10.1371/journal.pone.0320595
  5. Mechanisms of Change Underlying Effects of an Early Parenting Intervention on Child Development Among Vulnerable Families in Rwanda.
    Jensen SKG, Placencio-Castro M, Murray SM, Sezibera V, et al · · 2026 · PMID 41897057 · DOI 10.3390/children13030344
  6. Four-year follow-up to a home-visiting intervention to promote early childhood development and prevent family violence in rural Rwanda: the Sugira Muryango cluster randomised trial.
    Jensen SGK, Placencio-Castro M, Murray SM, Littman J, et al · · 2025 · PMID 40484411 · DOI 10.1136/bmjgh-2024-017866
  7. Promoting parent-child relationships and preventing violence via home-visiting:  A pre-post cluster randomised trial among Rwandan families linked to social protection programmes
    Betancourt TS, Jensen SK, Barnhart DA, Brennan RT, et al · · 2020 · DOI 10.21203/rs.2.13621/v4

Verify or expand the search:

Other trials of Sugira Muryango

Trials testing the same drug.

Other Boston College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02510313.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing